Details for Patent: 8,759,350
✉ Email this page to a colleague
Which drugs does patent 8,759,350 protect, and when does it expire?
Patent 8,759,350 protects ABILIFY and ABILIFY MYCITE KIT and is included in four NDAs.
This patent has fifty-three patent family members in thirty-one countries.
Summary for Patent: 8,759,350
Title: | Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders |
Abstract: | The pharmaceutical composition of the present invention comprises (1) a carbostyril derivative and (2) a serotonin reuptake inhibitor in a pharmaceutically acceptable carrier. The carbostyril derivative may be aripiprazole or a metabolite thereof, which is a dopamine-serotonin system stabilizer. The serotonin reuptake inhibitor may be fluoxetine, duloxetine, venlafaxine, milnacipran, citalopram, fluvoxamine, paroxetine, sertraline or escitalopram. The pharmaceutical composition of the present invention is useful for treating patients with mood disorders, particularly depression or major depressive disorder. |
Inventor(s): | Kikuchi; Tetsuro (Tokushima, JP), Iwamoto; Taro (Princeton, NJ), Hirose; Tsuyoshi (Tokushima, JP) |
Assignee: | Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP) |
Application Number: | 10/540,577 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,759,350 |
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 8,759,350
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Otsuka | ABILIFY | aripiprazole | SOLUTION;ORAL | 021713-001 | Dec 10, 2004 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ⤷ Try a Trial | ||||
Otsuka | ABILIFY | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 021729-002 | Jun 7, 2006 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ⤷ Try a Trial | ||||
Otsuka | ABILIFY | aripiprazole | TABLET, ORALLY DISINTEGRATING;ORAL | 021729-003 | Jun 7, 2006 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ⤷ Try a Trial | ||||
Otsuka | ABILIFY | aripiprazole | TABLET;ORAL | 021436-006 | Nov 15, 2002 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ⤷ Try a Trial | |||
Otsuka | ABILIFY | aripiprazole | TABLET;ORAL | 021436-005 | Nov 15, 2002 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,759,350
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2002-379003 | Dec 27, 2002 |
PCT Information | |||
PCT Filed | December 25, 2003 | PCT Application Number: | PCT/JP03/16724 |
PCT Publication Date: | July 22, 2004 | PCT Publication Number: | WO2004/060374 |
International Family Members for US Patent 8,759,350
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 042806 | ⤷ Try a Trial | |||
Argentina | 098599 | ⤷ Try a Trial | |||
Austria | 376419 | ⤷ Try a Trial | |||
Australia | 2003295235 | ⤷ Try a Trial | |||
Brazil | 0317771 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |